Novacyt announces AGM scheduled for June 19, 2025

Published 12/05/2025, 07:10
Novacyt announces AGM scheduled for June 19, 2025

PARIS, FRANCE - Novacyt (EPA:ALNOV) S.A. (EURONEXT GROWTH:ALNOV; AIM:NCYT), a global molecular diagnostics company, has announced that its Annual General Meeting (AGM) is set to take place at the Hilton Hotel, Paris Charles de Gaulle Airport, on Thursday, June 19, 2025. The meeting is scheduled for 1 pm CEST/12 pm BST and will be accessible to shareholders in person.

The company, known for its extensive portfolio of molecular assays and instrumentation, stated that a video recording of the AGM proceedings will be made available on the Novacyt website shortly after the event concludes. This move ensures that stakeholders unable to attend can stay informed about the company’s developments and decisions made during the AGM.

Novacyt operates across three main business segments: Clinical, Instrumentation, and Research Use Only. Its clinical segment offers a variety of in vitro diagnostic products and services, focusing on reproductive health, precision medicine, and infectious diseases. The instrumentation segment boasts advanced DNA sample preparation platforms and rapid PCR machines, while the Research Use Only segment provides high-performance qPCR assays and workflows for various sectors, including human health and environmental research.

With headquarters in Le Vésinet, France, and offices in the UK, Singapore, the US, and Canada, Novacyt maintains a commercial presence in over 65 countries. The company is listed on both the London and Paris stock exchanges under the tickers NCYT and ALNOV, respectively.

This information is based on a press release statement from Novacyt S.A. and provides shareholders and interested parties with the necessary details about the upcoming AGM, reflecting the company’s commitment to transparency and stakeholder engagement.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.